Get started
Alnylam Pharmaceuticals, Inc.
Short

Huge gap....

45
Current price is unattractive, expecting a lot of investors to cash out.
scorpioidk
Chart Patterns

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Chart Patterns
scorpioidk

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.